Lactic acid is highly concentrated in the TME and is known to exert immunosuppressive effects, particularly inhibiting the function of conventional T cells in vitro.32 Our study demonstrates that the inhibition of SRSF1, a well-characterized RNA splicing factor in tumor cells, can reduce lactic acid production, thereby enhancing the efficacy of cancer immunotherapy. This evidence concerns the gene SRSF1 and neoplasm.